| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.86 | $3.10 | $3.74 | $2.20 | $3.04 | $0.88 | $0.62 | $0.56 |
| EPS (Diluted) | $2.85 | $3.08 | $3.72 | $2.18 | $3.01 | $0.87 | $0.62 | $0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.9B | $9.8B | $10.0B | $9.6B | $7.2B | $6.7B | $5.9B | $5.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.1B | $0.2B | $0.2B | $0.8B | $0.6B | $0.1B | $0.1B |
| Total Liabilities | $8.5B | $8.5B | $8.7B | $8.5B | $6.4B | $5.8B | $5.1B | $5.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $1.3B | $1.2B | $1.1B | $0.8B | $0.8B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $-0.0B | $0.0B | $0.1B |
| Investing Cash Flow | $0.2B | $0.1B | $-0.4B | $-0.8B | $-0.5B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.3B | $0.2B | $-0.1B | $0.5B | $0.7B | $0.1B | $-0.1B |